asthma
chronic
inflammatori
diseas
respiratori
tract
predispos
individu
suffer
recurr
episod
symptom
wheez
cough
dyspnea
due
bronchial
obstruct
airway
obstruct
revers
either
spontan
medic
treatment
inflamm
caus
increas
sensit
airway
varieti
stimuli
increas
sensit
refer
bronchial
asthma
tradit
understood
misdirect
immun
reaction
environment
influenc
thu
believ
caus
inhal
allergen
latest
studi
howev
challeng
outlook
asthma
offer
new
insight
pathophysiolog
relationship
microbi
exposur
earli
well
success
infect
develop
asthma
furthermor
recent
scientif
work
point
lung
microbiom
differ
asthma
patient
healthi
subject
previous
lung
healthi
subject
consid
howev
clear
whether
perman
temporari
bacteri
colon
lung
conclus
due
absenc
microorgan
growth
cultur
media
know
detect
pathogen
germ
altogeth
experiment
epidemiolog
clinic
studi
establish
contemporari
hypothesi
modif
nativ
lung
microbiota
predispos
factor
develop
asthma
new
find
expand
common
explan
asthma
enorm
recent
insight
complic
lung
microbiota
emerg
asthma
rais
new
question
conduct
present
investig
better
understand
possibl
type
asthma
caus
spectrum
possibl
pathogen
microorgan
want
identifi
examin
respiratori
flora
asthmat
patient
therefor
collect
data
patient
variou
type
asthma
classifi
allerg
nonallerg
mix
unspecifi
form
accord
intern
classif
diseas
icd
examin
microbiom
hospit
databas
depart
intern
medicin
saarland
univers
medic
center
germani
varieti
test
organ
consist
bacteria
virus
fungi
airway
differ
type
asthmat
respiratori
infect
asthmat
diagnos
cultur
bronchial
mucu
agar
obtain
either
extract
bronchoalveolar
lavag
bronchial
aspir
throat
swab
sputum
product
aim
studi
clarifi
method
better
detect
pathogen
sputum
bronchial
asthma
patient
studi
design
clarifi
whether
pathogen
detect
infectionassoci
appear
interv
free
asthma
attack
identifi
caus
involv
case
asthma
develop
appropri
tailor
therapi
asthmat
studi
retrospect
examin
pathogen
spectrum
asthma
patient
collect
hospit
chart
data
depart
intern
medicin
saarland
univers
medic
center
studi
period
asthma
defin
chronic
inflammatori
diseas
respiratori
tract
character
bronchial
hyperreact
variabl
airway
obstruct
either
partial
complet
revers
asthmat
symptom
classifi
paroxysm
dyspnea
clinic
present
expiratori
stridor
coughvari
asthma
wheez
diagnosi
manifest
asthma
made
base
patient
medic
histori
clinic
examin
lung
function
bronchospasmolysi
asthma
classifi
case
accord
latest
edit
icd
compar
lung
microbiom
predominantli
allerg
asthma
nonallerg
asthma
mix
asthma
unspecifi
asthma
patient
studi
popul
mix
term
age
studi
group
includ
unselect
asthmat
asthma
attack
period
attackfre
interv
goal
studi
determin
whether
detect
pathogen
infectionassoci
type
asthma
indic
microbiolog
examin
perform
either
explicitli
suspect
respiratori
infect
otherwis
routin
microbiolog
test
explicitli
perform
pathogen
microb
virus
fungi
legionella
mycobacteria
nocardiasi
actinomycetal
pneumocysti
jiroveci
carinii
polymeras
chain
reaction
pcr
eg
atyp
pneumonia
pathogen
mycobacteria
secret
mouthnas
caviti
trachea
obtain
differ
depend
particular
case
commonli
appli
method
bronchoalveolar
lavag
tracheal
secret
throat
swab
sputum
bronchoalveolar
lavag
appli
context
bronchoscopi
case
ml
salin
solut
instil
local
anesthesia
aspir
fiberopt
bronchoscop
aspir
thu
obtain
deposit
differ
steril
specimen
trap
tracheal
suction
set
dahlhausen
medizintechnik
germani
tracheal
secret
also
collect
fiberopt
bronchoscopi
aspir
steril
specimen
trap
tracheal
suction
set
dahlhausen
medizintechnik
throat
swab
collect
commerci
cotton
swab
transport
system
copan
italia
brescia
itali
rotat
swab
slight
pressur
palat
arch
asthma
patient
sputum
recov
expector
ml
steril
sputum
collect
tube
salivett
sarstedt
germani
sent
laboratori
analysi
collect
sampl
sputum
tracheal
bronchial
secret
test
sampl
transport
suitabl
contain
institut
microbiolog
virolog
propag
sputum
steril
petri
dish
test
dark
background
macroscop
evalu
perform
determin
whether
slimi
purul
bloodi
thereaft
bronchial
secret
pu
constitu
saliva
separ
needl
eye
support
share
use
microscop
examin
microscop
examin
done
gram
stain
magnif
least
visual
field
accord
criteria
bartlett
typic
morpholog
larger
number
suspect
diagnosi
pathogen
microscop
bacteriolog
examin
accord
microbiolog
infectiolog
qualiti
standard
express
semiquantit
determin
squamou
epithelia
granulocyt
microorgan
perform
subsequ
solid
cultur
media
appli
cultiv
common
aerob
fastgrow
microorgan
base
cultur
approach
columbia
agar
sheep
blood
oxoid
wesel
germani
agar
becton
dickinson
heidelberg
germani
use
incub
hour
gener
cultur
medium
growth
discoveri
streptococcu
pneumonia
streptococcu
pyogen
staphylococcu
auereu
escherica
coli
shigella
flexner
gassner
agar
waterblu
lactos
agar
oxoid
oper
detect
enterobacteriacea
test
enterobacteriacea
e
coli
shigella
klebsiella
proteu
mirabili
enterobact
sp
citrobact
sp
serratia
marcescen
salmonella
yersinia
medium
wilkinschalgren
anaerob
agar
oxoid
contain
columia
agar
nalidix
acid
gener
growth
anaerob
use
antimicrobi
suscept
test
chocol
agar
oxoid
blood
agar
base
wesel
germani
use
variant
blood
agar
brief
heat
agar
lysi
erythrocyt
achiev
result
hemin
factor
x
nicotinamid
adenin
dinucleotid
factor
releas
agar
metabol
bacteria
hemolyt
absent
cook
blood
plate
sometim
incub
elev
carbon
dioxid
tension
capnophil
germ
like
haemophilu
influenca
brucella
campylobactor
multipli
much
better
macconkey
agar
oxoid
use
select
medium
detect
gramneg
bacteria
sabouraud
agar
oxoid
work
cultiv
differenti
fungi
pcr
use
detect
adenoviru
coronaviru
coxsacki
echo
viru
cytomegaloviru
viru
herp
simplex
influenza
virus
b
parainfluenza
respiratori
synctial
viru
rhinoviru
enteroviru
varicellazost
viru
mechan
properti
lung
lung
volum
measur
use
bodi
plethysmographi
jaeger
masterscreen
bodi
germani
inclus
criteria
studi
patient
asthma
whose
tracheal
secret
examin
microbiolog
pathogen
germ
patient
asthma
subject
microbiolog
test
exclud
studi
consid
follow
paramet
bodi
plethysmographi
studi
forc
expiratori
volum
first
second
inspiratori
vital
capac
vcin
total
lung
capac
tlc
tiffeneau
index
vcin
measur
exhal
nitric
oxid
feno
express
part
per
billion
ppb
determin
chemiluminesc
analyz
flow
control
asthmat
blood
ga
analysi
perform
obtain
blood
earlob
patient
minut
rub
circulationrais
ointment
finalgon
cream
nonivamidebutoxyethyl
nicotin
boehring
ingelheim
pti
limit
ingelheim
rhein
germani
oxygen
carbon
dioxid
ph
scale
measur
blood
ga
analyz
flex
radiomet
ltd
willich
germani
refer
rang
blood
ga
analysi
ph
scale
mm
hg
oxygen
mm
hg
carbon
dioxid
prick
test
carri
part
allerg
asthma
diagnosi
common
test
liquid
allergen
dust
mite
grass
pollen
anim
hair
epithelia
etc
introduc
surfac
layer
skin
mean
scratch
wait
time
minut
skin
reaction
measur
templat
provid
total
immunoglobulin
e
ige
human
serum
plasma
determin
aid
diagnosi
allerg
diseas
blood
sampl
ige
collect
use
sarstedt
serum
monovett
ml
brown
top
blood
collect
system
multifli
blood
collect
needl
electrochemiluminesc
immunoassay
eclia
perform
determin
ige
elecsi
cobas
immunoassay
analyz
roch
diagnost
ltd
mannheim
germani
normal
refer
rang
ige
defin
iuml
creactiv
protein
crp
human
serum
plasma
measur
quantit
sampl
collect
lithium
heparin
sarstedt
monovett
ml
orang
top
use
standard
immunoturbidometr
assay
coba
integra
system
normal
valu
less
mgl
flow
cytometri
use
determin
differenti
white
blood
cell
count
neutrophil
normal
rang
eosinophil
normal
rang
collect
edta
monovett
ml
sarstedt
germani
leukocyt
count
normal
rang
blood
determin
gener
routin
part
small
larg
blood
count
collect
edta
monovett
ml
flow
cytometri
examin
longterm
oxygen
therapi
oxygen
mm
hg
carbon
dioxid
mm
hg
predispos
factor
bacteri
colon
asthma
allerg
condit
studi
factor
favor
colon
pathogen
bronchial
asthma
includ
allerg
rhiniti
allerg
conjunct
atop
dermat
food
allergi
drug
allergi
analyz
case
select
obstruct
pulmonari
diseas
copd
gastroesophag
reflux
diseas
obes
predispos
factor
develop
asthma
also
bacteri
colon
patient
length
hospit
stay
compar
patient
differ
form
asthma
without
detect
infect
saarland
institut
review
board
approv
studi
due
retrospect
natur
studi
protocol
medic
associ
saarland
institut
review
board
waiv
need
inform
consent
written
inform
consent
waiv
studi
use
retrospect
analysi
patient
medic
record
patient
data
anonym
prior
analysi
data
express
proport
mean
standard
deviat
wherev
appropri
calcul
confid
interv
ci
total
number
patient
asthma
microbi
attack
chisquar
test
independ
standard
normal
variabl
probabl
use
compar
associ
microbiom
differ
type
asthma
fisher
exact
test
variabl
probabl
use
evalu
sex
differ
associ
infect
diagnost
tool
bacteria
virus
fungi
differenti
microb
prick
test
food
drug
allergi
allerg
comorbid
differ
type
asthma
oneway
analysi
varianc
anova
independ
sampl
perform
compar
age
differ
blood
test
lung
function
test
feno
blood
ga
analysi
durat
hospit
stay
among
asthma
group
test
express
p
valu
consid
statist
signific
hospit
databas
found
patient
differ
type
asthma
treat
depart
intern
medicin
univers
hospit
saarland
germani
studi
period
total
patient
asthma
met
inclus
criteria
trial
total
ci
patient
asthma
infest
germ
microbiolog
detect
tracheal
secret
patient
group
diagnos
nonspecifi
asthma
follow
allerg
asthma
sames
small
group
nonallerg
mix
asthma
tabl
follow
result
studi
could
find
evid
microorgan
causal
sourc
asthma
p
tabl
acut
infect
thu
play
role
bacteri
colon
respiratori
tract
asthmat
p
one
smallest
group
studi
mix
asthma
compar
prone
microbi
attack
caus
acut
infect
contrast
acut
infect
play
signific
role
allerg
asthmat
secondlargest
group
microbi
contamin
respiratori
tract
p
static
signific
differ
found
group
term
age
distribut
p
rel
women
affect
germ
without
statist
signific
p
except
group
allerg
asthma
diagnost
tool
influenc
microbiolog
result
asthmat
tabl
comparison
differ
speci
show
increas
incid
individu
microb
staphylococcu
aureu
respiratori
synctial
viru
candida
albican
without
statist
signific
tabl
comparison
blood
test
lung
function
test
feno
blood
ga
analysi
result
reveal
signific
differ
asthma
group
tabl
skin
allergi
test
present
variou
medic
diagnos
allergi
group
asthma
patient
tabl
differ
found
group
compar
allergen
nonallerg
asthmat
allerg
adhes
although
asthmat
plaster
allergi
studi
p
comparison
food
drug
allergi
group
without
statist
signific
tabl
allergi
variou
comorbid
investig
studi
show
statist
differ
asthma
group
tabl
durat
hospit
stay
day
allerg
asthma
group
nonallerg
mix
nonspecifi
statist
signific
differ
p
base
present
find
unabl
identifi
microbiolog
colon
airway
asthmat
studi
popul
detect
pathogen
agent
occur
asthmat
studi
therefor
appear
direct
correl
asthma
microbiom
evid
germ
occur
mainli
context
acut
respiratori
infect
without
statist
signific
asthmat
trial
pathogenesi
asthma
like
vari
combin
genet
polymorph
environment
factor
suspect
lead
develop
current
data
microbiom
respiratori
tract
demonstr
noteworthi
differ
number
varieti
microbi
commun
healthi
subject
recent
advanc
cultiv
germ
establish
new
molecular
techniqu
contribut
identif
new
find
support
assumpt
connect
divers
microbi
exposur
earli
life
develop
atop
diseas
earli
colon
respiratori
tract
earli
life
increas
risk
later
develop
asthma
bacteri
colon
respiratori
tract
appear
affect
cours
convinc
evid
previou
human
rhinoviru
respiratori
syncyti
viru
infect
associ
increas
risk
develop
found
respiratori
virus
airway
asthmat
case
studi
abl
make
connect
respiratori
virus
asthma
data
obtain
studi
although
evalu
earlier
childhood
infect
respiratori
virus
studi
popul
recent
studi
demonstr
colon
unrel
speci
atyp
bacteria
mycoplasma
pneumonia
chlamydophila
pneumonia
respiratori
tract
peopl
contribut
develop
well
known
acut
respiratori
infect
favor
exacerb
despit
rel
larg
number
public
relationship
organ
asthma
clear
evid
link
germ
asthma
still
although
abl
detect
c
pneumonia
bronchoalveolar
lavag
patient
allerg
asthma
infectionfre
period
unabl
identifi
germ
major
asthmat
therefor
believ
result
show
associ
c
pneumonia
exacerb
asthma
similar
result
also
obtain
serolog
test
chlamydophila
pneumoniaspecif
antibodi
larg
contrast
unabl
identifi
pneumonia
investig
use
pcr
tracheal
secret
asthmat
studi
therefor
confirm
link
pneumonia
exacerb
asthma
inconsist
find
regard
possibl
connect
atyp
bacteria
asthma
may
due
difficulti
microbiolog
identifi
organ
atyp
bacteria
fastidi
difficult
grow
bath
cultur
usual
condit
therefor
serolog
test
commonli
use
detect
antibodi
type
germ
detect
organ
previou
recent
studi
use
pcr
detect
atyp
new
discoveri
type
bacteria
pneumonia
haemophilu
influenza
moraxella
catarrhali
combin
organ
correl
although
data
concern
bacteria
collect
childhood
asthma
bisgaard
et
al
found
microorgan
mainli
nonspecifi
follow
allerg
asthma
patient
studi
klemet
et
also
report
work
asthmat
increas
risk
infect
pneumonia
howev
bacteria
detect
major
patient
asthma
studi
find
statist
signific
relationship
bacteria
asthma
studi
although
studi
confirm
causal
bacteria
develop
asthma
previous
publish
data
contribut
stimul
live
discuss
relationship
sever
type
bacteria
risk
prognosi
asthma
current
medic
hosoki
et
report
aureu
affect
cours
onset
asthma
aureu
induc
signific
distribut
eosinophilderiv
neurotoxin
gener
superoxid
product
cytokin
chemokin
aureu
may
connect
exacerb
asthma
eosinophil
inflamm
asthma
aureu
directli
activ
eosinophil
via
plateletactiv
factor
detect
aureu
mainli
allerg
asthmat
studi
howev
associ
aureu
asthma
confirm
result
due
small
number
patient
aureu
infect
studi
popul
h
influenza
one
commonli
isol
bacteria
chronic
respiratori
diseas
respiratori
infect
caus
h
influenza
allerg
respiratori
diseas
lead
chronic
respiratori
infect
featur
neutrophil
unsurprisingli
abl
identifi
differ
type
haemophilu
bacteria
airway
mani
studi
patient
howev
still
unabl
demonstr
associ
asthma
differ
speci
haemophilu
bacteria
may
simpli
case
speci
haemophilu
often
caus
gener
bacteri
respiratori
infect
human
soriano
et
exampl
often
found
h
influenza
haemophilu
parainfluenza
catarrhali
studi
adult
patient
respiratori
tract
infect
nishioka
et
also
report
increas
incid
respiratori
tract
pathogen
antimicrobi
suscept
pneumonia
h
influenza
catarrhali
isol
outpati
respiratori
infect
respiratori
infect
often
blame
exacerb
copd
asthma
attack
case
copd
philit
et
al
identifi
bacteria
h
influenza
pneumonia
pseudomona
aeruginosa
among
virus
recov
influenza
viru
respiratori
syncyti
viru
domin
studi
case
acut
asthma
infecti
agent
shown
name
pneumonia
influenza
respiratori
syncyti
viru
parainfluenza
earlier
respiratori
infect
discov
p
aeruginosa
intens
care
perhap
microorgan
gener
caus
respiratori
infect
infect
caus
p
aeruginosa
belong
class
opportunist
pathogen
frequent
risk
infect
hospit
due
high
phenotyp
due
current
databas
limit
yet
known
whether
fungi
fungal
allergen
relev
exacerb
overwhelm
evid
common
extern
trigger
asthma
includ
fungi
diagnosi
fungal
allergi
determin
either
skin
test
antigen
deriv
fungi
measur
specif
ige
level
number
fungi
multipl
speci
aspergillosi
known
trigger
asthma
earlier
research
found
fungu
speci
candida
implic
whether
relationship
causal
import
asthma
determin
base
avail
data
elev
level
nitric
oxid
found
breath
asthmat
increas
level
nitric
oxid
measur
lower
respiratori
although
concentr
nitric
oxid
analyz
patient
asthma
studi
sampl
examin
reveal
notabl
elev
level
nitric
oxid
studi
popul
recent
studi
demonstr
noninvas
techniqu
induc
sputum
find
feno
provid
result
reliabl
tradit
goldstandard
method
bronchoalveolar
lavag
bronchial
aspir
flexibl
bronchoscopi
diagnos
noninvas
techniqu
much
pleasant
patient
analysi
feno
use
diagnos
asthma
addit
induc
sputum
use
biolog
medium
diagnosi
asthma
determin
harm
dust
bronchoscopi
bronchoalveolar
lavag
becom
import
diagnost
tool
although
patient
subject
bronchoscopi
studi
superior
bronchoalveolar
lavag
bronchial
aspir
sputum
examin
could
determin
microbiolog
analysi
tracheal
secret
studi
examin
microbiolog
growth
microorgan
tracheal
secret
patient
differ
type
asthma
variou
techniqu
one
depart
intern
medicin
present
studi
examin
patient
asthma
episod
infect
also
includ
asthmat
infectionfre
interv
neither
abl
identifi
increas
incid
microorgan
patient
variou
type
asthma
episod
infect
infectionfre
period
base
data
studi
unabl
find
infecti
etiolog
asthma
